欢迎进入 投资云南@云南招商网

州市招商

文山

项目查询

关键字:
所属行业:
投资金额:
- 万元
 
您现在的位置是: 首页--生物医药和大健康--详细
分子诊断试剂生产项目 Molecular Diagnostic Reagents Production Project
发布时间:2016-07-07 14:35:59   来源:本站   作者:   点击:471次

Name

分子诊断试剂生产项目

Molecular Diagnostic Reagents Production Project

Industry Involved

Modern bio-medicine

Site

Southern Block of Yuxi National High-tech Industrial Development Zone

Description

This project is invested by Kunming University of Science and TechnologyIndustry Management Co., Ltd. relying on Research Center of Molecular Medicine of Yunnan Province, Faculty of Life Science and Technology of Kunming University Science and Technology and Yunnan Academy of Applied Technology, and is to be put into construction in Yuxi High-tech Industrial Development Zone. In this project, 2.5 million serial standard products for laboratory diagnosis, 1 million rapid detection kits and ancillary products for antibiotic resistance, 4 million serial pathogen-typing kits and other series of molecular diagnostic products involving the early detection of genetic heart diseases would be produced. Oriented by serialization and localizationcost-effective products, with local advantages, would break the monopoly of foreign brands.

Content

Construction scale: The total floor area is 10950 m2. It includes the construction of manufacturing workshop for serial standard products for laboratory diagnosis, manufacturing workshop for detection kits for antibiotic resistance, manufacturing workshop for serial pathogen-typing kits, manufacturing workshop for early detection kits for genetic heart diseases, raw materials warehouse, finished products warehouse, comprehensive office building, living quarters and public utilities.

Construction duration: 2 years

Land area: 14.8 mu

Supporting Conditions

Yuxi is the traffic hub for Yunnan’s southward development focusing on South Asia and Southeast Asia as well as one of the core cities for the Central Yunnan Urban Economic Circle. Yuxi National High-tech Industrial Development Zone (“Yuxi High-tech Zone”) is located in central Yuxi City and its overall planned area is 43.79 km2. The southern block, with a planned area of 6.08 km2, is to become a modern park oriented to developing cigarette industry, cigarette and tobacco supporting materials and bio-pharmacy, and striving to develop headquarters economy, finance and insurance, and R&D and trade centers. In 2014, this zone realized a total output value of RMB 43.16 billion, with a year-on-year growth of 8.2% and accounting for 36.4% the total output value of the whole city. There are15 biomedical enterprises including Walvax Biotechnology Co., Ltd., Weihe Pharma and Jiankun BioPharma settling down in the zone. This project relies on Yunnan Provincial Molecular Medicine Research Center which was jointly established by Kunming University of Science and Technology,Yunnan Provincial Science and Technology Department and the First People's Hospital of Yunnan Province. It has better advantages in policy support, scientific research strength, product R & D, combination of bases and clinics, domestic and foreign cooperation and others. The current diagnostic reagent products have the industrialization conditions. At present, the regulatory detailed planning for the southern block has been finished and this project is ready for construction.

Investment Estimate and Fund Raising

Investment estimate: The total investment of this project is RMB 117.835 million, of which the fund raised by enterprises is RMB 37.835 million and the fund raised from financial institutions is RMB 80 million.

Fund raising: self raising by enterprise and bank loans

Preferential Policies Applicable

Preferential Policies for Investment Promotion of Yuxi National High-tech Zone

Market Prediction (Analysis)

Molecular diagnostics refers to detecting the genetic materials of the detected subjects or the genetic structures and types of viruses by means of molecular biology to detect and diagnose diseases from the gene level. Molecular diagnostics is one of the most important fields of in-vitro diagnostic (IVD), and it is a sub-sector requiring the highest technical level and undergoing the fastest growth in the industry. In 2014, the global IVD market scale was about $ 50 billion, with an average annual growth rate of 7%-8%, and the figure is expected to exceed $70 billion in 2019. In 2014, the IVD market scale in China was about RMB 28.7 billion, with an average annual growth rate of 18%, and the figure is expected to exceed RMB 70 billion in 2019. In 2014, the global molecular diagnostic market scale reached $ 6.2 billion, while the scale in China was about RMB 3 billion, only accounting for around 6% of the global market. Roche, Novartis and Hologic are globally leading enterprises in the field of molecular diagnostics. The domestic molecular diagnostic industry sees an initial market pattern of “2+X” headed by Daan Gene and BGI. At present, China's molecular diagnostic industry is still in the initial stage of development, with the aging of population and the transformation of medical model, market demand for molecular diagnostics will continue to increase. This project will have a good market prospect

Profit Model and Preliminary Benefit Analysis

Economic benefit: After this project reaches the design capacity, the annual sales revenue of series of molecular diagnostic reagent products may reach RMB 98.5 million, with a corporate income tax of RMB 9.079 million; the annual net profit may reach RMB 27.236 million; the payback period is 6.3 years (including 2 years for construction).

Social benefit: This project will promote the development of the bio-medicine industry in Yuxi City, extend industrial chain and increase job opportunities.

Risk Analysis

In this project, there may be some uncertainties including longer product approval period and higher R & D cost.

Cooperation Pattern

Joint venture and equity participation

Contact Information

Contact Unit: Investment Promotion Bureau of Administrative Committee of Yuxi High-tech Zone

Contact Person: Ma Yanqing

Tel: 0877-6562722

Fax:  0877-2069302

E-mail: yxgxq@126.com

关于我们| 商会平台| 信息公开| 联系我们 滇ICP备08002862号

0871-67195654/67195610

电子邮件:yunnanzs@163.com

云南招商官方微信

法制在线官方微信

管理员登录      不良信息报警      云南网监      网站备案      平台入口      招商大数据平台项目查询系统